Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

25.16
-0.1300-0.51%
Post-market: 25.160.00000.00%19:30 EDT
Volume:1.78M
Turnover:44.85M
Market Cap:3.15B
PE:116.80
High:25.78
Open:25.64
Low:25.01
Close:25.29
52wk High:31.77
52wk Low:19.30
Shares:125.07M
Float Shares:111.18M
Volume Ratio:0.74
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2154
EPS(LYR):-0.1269
ROE:15.86%
ROA:5.09%
PB:14.27
PE(LYR):-198.33

Loading ...

Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 15, 2021

Major Issues Report

8-K - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
Sep 29, 2020

Correspondence

CORRESP [Cover] - Correspondence
Sep 29, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Sep 29, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Major Issues Report

8-K - Current report